© PR Newswire
04.03.2025
RAY B
LISTED
STO
The Chinese carbon ion center Heyou Hospital selects RayStation
News Preview
STOCKHOLM, March 4, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that Heyou Hospital, located in Foshan City, Guangdong Province, China, has placed an order for the treatment planning system RayStation®*. Total order value (including service contract) is RMB 51 million (approximately SEK 77 million), of which RMB 1...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.03.2025
IBAB
LISTED
EURONEXT
IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in India
News Preview
Louvain-La-Neuve, Belgium, March 04, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a term sheet with Apollo Hospitals Enterprise Limited (AHEL) for the supply of one Proteus®ONE1 compac...
Themefolio
Profiler
Peergroup
© EQS Newswire
04.03.2025
ILM1
LISTED
XETR
Deutlicher Ergebnis- und Margenanstieg – Positiver Ausblick für 2025
News Preview
PressemitteilungVorläufige Geschäftszahlen der Medios AG 2024: Deutlicher Ergebnis- und Margenanstieg – Positiver Ausblick für 2025
Vorläufige Zahlen 2024
Umsatz steigt auf ca. 1,9 Mrd. € (+5,5 %)
Überproportionaler Anstieg des EBITDA pre1 auf ca. 79 Mio. € (+31 %); EBITDA-pre1-Marge deutlich verbessert auf ca. 4,2 % (Vj. 3,4 %)
Starker Anstieg......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© EQS Newswire
04.03.2025
ILM1
LISTED
XETR
Significant increase in earnings and margins – positive outlook for 2025
News Preview
Press release
Preliminary figures for Medios AG 2024: Significant increase in earnings and margins – positive outlook for 2025
Preliminary figures 2024
Revenue increases to around €1.9 billion (+5.5%)
Disproportionate increase of EBITDA pre1 to around €79 million (+31%); EBITDA pre1 margin significantly improved to around 4.2% (previous year: 3.4......
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© EQS Newswire
04.03.2025
EVT
LISTED
XETR
Evotec gibt wichtige Fortschritte in der Neurologie-Partnerschaft mit Bristol Myers Squibb bekannt
News Preview
Laufende strategische Partnerschaft bringt gemeinsame Pipeline in der Neurodegenerationsforschung voran
Evotec erhält eine Zahlung von 20 Millionen Dollar, um die Forschung weiter voranzutreiben
Hamburg, 04 März 2025:
Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute einen we......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.03.2025
EVT
LISTED
XETR
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
News Preview
Ongoing strategic partnership advances joint pipeline in neurodegeneration research
Evotec receives a $20 million payment to further progress research
Hamburg, Germany, 04 March 2025:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced another major accomplishment in its long......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.03.2025
EVT
LISTED
XETR
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
News Preview
Ongoing strategic partnership advances joint pipeline in neurodegeneration researchEvotec receives a $20 million payment to further progress research HAMBURG, DE / ACCESS Newswire / March 4, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN:DE0005664809; NASDAQ:EVO) today announced another major accomplishment in its long-standing n...
Themefolio
Profiler
Peergroup
© BusinessWire
03.03.2025
AMRX
LISTED
NASDAQ
Amneal’s BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, and mAbxience (“mAbxience”) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics Licensing Application (BLA) for two proposed denosumab biosimilars referencing Prolia® and XGEVA®. mAbxience...
Themefolio
Profiler
Peergroup
© EQS Newswire
03.03.2025
FRE
LISTED
XETR
Fresenius kündigt hiermit die Absicht an, ihren Anteil an der Fresenius Medical Care AG von derzeit rund 32,2 % auf nicht weniger als 25 % plus eine Aktie zu reduzieren
News Preview
DIESE MITTEILUNG, EINSCHLIESSLICH DER DARIN ENTHALTENEN INFORMATIONEN, UNTERLIEGT EINSCHRÄNKUNGEN UND IST NICHT ZUR WEITERGABE, VERÖFFENTLICHUNG ODER VERBREITUNG IN DEN ODER IN DIE VEREINIGTEN STAATEN VON AMERIKA, AUSTRALIEN, KANADA, JAPAN, SÜDAFRIKA ODER IN EINE ANDERE RECHTSORDNUNG, IN DER DIE VERBREITUNG, VERÖFFENTLICHUNG ODER WEITERGABE UNRECHT......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.03.2025
FRE
LISTED
XETR
Fresenius announces its intention to reduce its stake in Fresenius Medical Care AG from currently around 32.2% to no less than 25% plus one share
News Preview
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.
THIS ANNOUNCEMENT IS FOR INFOR......
Themefolio
Profiler
Peergroup
© Globe Newswire
03.03.2025
EAPI
LISTED
EURONEXT
Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan driven by enhanced effectiveness and financial discipline
News Preview
Full-year 2024 results1: Operational resilience and strong increase in Free Cash Flow before financing in a challenging environment...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS3 March 2025 at 16.30 EET ...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
03.03.2025
FYB
LISTED
XETR
FYB202/Otulfi® (ustekinumab-aauz), a biosimilar to Stelara®, launched in the United States and the European Union
News Preview
Press Release // March 3, 2025
FYB202/Otulfi ® (ustekinumab-aauz), a biosimilar to Stelara®, launched in the United States and the European Union
FYB202/Otulfi ® is now commercially available in both subcutaneous and intravenous formulations in the United States and the European Union
Patient transition to Otulfi® supported by comparable effic......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.03.2025
FYB
LISTED
XETR
Markteinführung von FYB202/Otulfi® (ustekinumab-aauz), einem Biosimilar zu Stelara® in den USA und der Europäischen Union
News Preview
Pressemitteilung // 3. März 2025
Markteinführung von FYB202/Otulfi® (ustekinumab-aauz), einem Biosimilar zu Stelara® in den USA und der Europäischen Union
FYB202/Otulfi® ist ab sofort in den USA und der Europäischen Union in subkutaner und intravenöser Formulierung erhältlich
Behandlungsumstellung auf Otulfi® wird durch vergleichbare Wirksamkei......
Themefolio
Profiler
Peergroup
© Globe Newswire
03.03.2025
POAI
LISTED
NASDAQ
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
News Preview
Predictive receives first tranche of financing to initiate integration of AI/ML platform technologies, core laboratory capabilities and business development efforts in Europe and the United States...
Themefolio
Profiler
Peergroup
© BusinessWire
03.03.2025
ZLAB
LISTED
NASDAQ
Zai Lab Announces Participation in Investor Conferences in March 2025
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in March 2025:
Leerink Partners 2025 Global Healthcare Conference
Fireside Chat: Monday, March 10, 2025, 9:20 a.m. EST
Location: Miami, FL
Jefferies Biotech on the Beach Summit
T...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.03.2025
IMCR
LISTED
NASDAQ
Immunocore to present at upcoming investor conferences
News Preview
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, 03 March 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases a...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.03.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
Themefolio
Profiler
Peergroup
© PR Newswire
03.03.2025
IMMNOV
LISTED
STO
Immunovia's CLARITI study results selected for prestigious presentation at the world's largest gastroenterology conference
News Preview
LUND, Sweden, March 3, 2025 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the results of its CLARITI study have been selected for a distinguished plenary presentation at the upcoming Digestive Disease Week® (DDW) 2025 conference, taking place May 5, 2025.
The CLARITI study w...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.02.2025
GMAB
LISTED
CPH
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.02.2025
GMAB
LISTED
CPH
Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.02.2025
BAVA
LISTED
CPH
Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older
News Preview
COPENHAGEN, Denmark, February 28, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the European Commission has granted marketing authorization in Europe for VIMKUNYA® for active immunization for the prevention of disease caused by chikungunya virus in individuals 12 years and older....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.02.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Outi Vaarala
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 28 FEBRUARY 2025 at 17.45 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.02.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Niclas Lindstedt
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 28 FEBRUARY 2025 at 17.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.02.2025
ORY
LISTED
BME
ORYZON Announces the Voting Results of February 2025 Extraordinary General Shareholders' Meeting
News Preview
MADRID, Spain and CAMBRIDGE, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics S.A., a clinical-stage biopharmaceutical company focused on epigenetics for the development of therapies for diseases with significant unmet medical needs, today announced the results of voting at the Extraordinary General Shareholders' Meeting held today in Mad...
Themefolio
Profiler
Peergroup
© PR Newswire
28.02.2025
BIOA B
LISTED
STO
The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU
News Preview
STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has reaffirmed its positive opinion for the anti-Aβ monoclonal antibody lecanemab (Leqembi®), adopted in November 2024. Follo...
Themefolio
Profiler
Peergroup
© PR Newswire
28.02.2025
BIOA B
LISTED
STO
The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU
News Preview
STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has reaffirmed its positive opinion for the anti-Aβ monoclonal antibody lecanemab (Leqembi®), adopted in November 2024. Follo...
Themefolio
Profiler
Peergroup
© PR Newswire
28.02.2025
ALK B
LISTED
CPH
U.S. FDA Approves Label Expansion for ALK's ODACTRA® (House Dust Mite Allergen Tablet) for Sublingual Use as Immunotherapy to Now Include Children with House Dust Mite Allergy
News Preview
- ODACTRA is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in children ages 5 through 11 years, in addition to patients 12 through 65 years of age –
- House dust mites are a common cause of allergies in children and can cause symptoms year-round1 -
BEDMINSTER, N.J., Feb. 28, 2025 /PRNewswi...
Themefolio
Profiler
Peergroup
© BusinessWire
28.02.2025
AMRX
LISTED
NASDAQ
Amneal Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced its results for the fourth quarter and full year ended December 31, 2024.
“Amneal’s continued success in 2024 demonstrates our ability to drive sustainable growth through disciplined execution, continuous innovation, and strategic capital allocation. All thre...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.02.2025
RXRX
LISTED
NASDAQ
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
News Preview
SALT LAKE CITY, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its fourth quarter and fiscal year ended December 31, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.02.2025
SKYE
LISTED
NASDAQ
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on February 24, 2025, the Board of Directors granted a non-qualified stock option award to purchase 56,000 shares of its com...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.02.2025
ANAB
LISTED
NASDAQ
Anaptys Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
News Preview
SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial results for the fourth quarter and year ended December 31, 2024, and provided a business update....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.02.2025
ANAB
LISTED
NASDAQ
Anaptys Announces Participation in March Investor Conferences
News Preview
SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in mu...
Themefolio
Profiler
Peergroup
© BusinessWire
27.02.2025
TFX
LISTED
NYSE
TFX BREAKING NEWS: Teleflex Incorporated 20% Stock Drop Triggers Securities Fraud Investigation; Investors are Urged to Contact BFA Law if they Suffered Losses
News Preview
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Teleflex Incorporated (NYSE: TFX) for potential violations of the federal securities laws.
If you invested in Teleflex, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/teleflex-incorporated.
Why...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.02.2025
EUZ
LISTED
XETR
Eckert & Ziegler und Bicycle Therapeutics schließen strategische Partnerschaft zur Lieferung von Radioisotopen sowie zur Entwicklung und Produktion von Bicycle Radio Conjugates
News Preview
Berlin, Deutschland, 27. Februar 2025. Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX), ein führender Anbieter von Isotopentechnologie für medizinische, wissenschaftliche und industrielle Anwendungen, hat heute eine weitreichende strategische Partnerschaft mit Bicycle Therapeutics (NASDAQ: BCYC) bekannt gegeben. Das Pharmaunternehmen entwic......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.02.2025
EUZ
LISTED
XETR
Eckert & Ziegler Enters Strategic Partnership with Bicycle Therapeutics for Radioisotope Supply and Contract Development and Manufacturing of Bicycle Radio Conjugates
News Preview
Berlin, Germany, 27 February 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX), a leading provider of isotope technology for medical, scientific, and industrial use, today announced a comprehensive strategic partnership with Bicycle Therapeutics (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeuti......
Themefolio
Profiler
Peergroup
© BusinessWire
27.02.2025
ZLAB
LISTED
NASDAQ
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the fourth quarter and full-year 2024, along with recent product highlights and corporate updates.
“2024 was a defining year for Zai Lab, marked by strong sales growth, financial strength, and significant pipeline progress. As we look ahead, 2025 is set to be a tran...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.02.2025
TFX
LISTED
NYSE
Teleflex Announces Quarterly Dividend
News Preview
WAYNE, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 17, 2025, to shareholders of record at the close of business on March 7, 2025. Additional information a...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.02.2025
TFX
LISTED
NYSE
Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
News Preview
Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.02.2025
AFX
LISTED
XETR
ZEISS VISUMAX 800 with SMILE pro software receives approval in China
News Preview
ZEISS VISUMAX 800 with SMILE pro software receives approval in China
Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow enhancements.
JENA,(Germany), SHANGHAI, (China), | 27 February 2025 | Carl Zeiss Meditec AG
ZEISS Medical Technology announced to......
Themefolio
Profiler
Peergroup
© Globe Newswire
27.02.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Hao Pan
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 27 FEBRUARY 2025 at 11.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.02.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Satu Ahomäki
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 27 FEBRUARY 2025 at 11.00 EET ...
Themefolio
Profiler
Peergroup
© PR Newswire
27.02.2025
SECT_B
LISTED
STO
Invitation to presentation of Sectra's nine-month interim report 2024/2025
News Preview
LINKÖPING, Sweden, Feb. 27, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) invites investors, analysts, and the media to a presentation of the company's nine-month report with President Torbjörn Kronander and CFO Jessica Holmquist.
Publication of the financial report: 8:15 a.m. (CET) on March...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.02.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
The Executive Leadership Team members eligible for the Novozymes A/S 2022-2024 incentive program has on February 26, 2025, received the allocated shares. An overview of the number and value of shares allotted is provided on the attached file....
Themefolio
Profiler
Peergroup
© PR Newswire
27.02.2025
SOBI
LISTED
STO
US FDA grants Priority Review to Sobi's supplemental Biologics Licence Application (sBLA) for Gamifant® (emapalumab-lzsg)
News Preview
STOCKHOLM, Feb. 27, 2025 /PRNewswire/ -- Sobi® (STO: SOBI), today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for Gamifant® (emapalumab-Izsg) for use in adult and paediatric patients with hemophagocytic lymphohistiocytosis (HLH)/macrophage activation syndrome (MAS)...
Themefolio
Profiler
Peergroup
© PR Newswire
27.02.2025
INDV
LISTED
NASDAQ
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer
News Preview
RICHMOND, Va., Feb. 27, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) has appointed Joe Ciaffoni, currently an Independent Non-Executive Director of the Company, as Chief Executive Officer. The terms of his appointment are subject to, and effective upon, the approval by shareholders of a new remuneration policy at the Company's AGM in May...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.02.2025
SOON
LISTED
SIX
Sonova schärft das Bewusstsein für Hörgesundheit weltweit
News Preview
Sonova Holding AG
/ Schlagwort(e): Sonstiges
Sonova schärft das Bewusstsein für Hörgesundheit weltweit
27.02.2025 / 07:00 CET/CEST
Group Media Release
Kurz vor dem Welttag des Hörens am 3. März beteiligt sich Sonova Holding AG (SWX: SOON) an weltweiten Bemühungen zur Förderung der Hörgesundheit. Im Bewusstsein der erheb......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.02.2025
SOON
LISTED
SIX
Sonova raises awareness for hearing health globally
News Preview
Sonova Holding AG
/ Key word(s): Miscellaneous
Sonova raises awareness for hearing health globally
27.02.2025 / 07:00 CET/CEST
Group Media Release
With World Hearing Day on March 3 approaching, Sonova Holding AG (SWX: SOON) is participating in global efforts to promote hearing health. Recognizing the significant impact ......
Themefolio
Profiler
Peergroup
© Globe Newswire
27.02.2025
IBAB
LISTED
EURONEXT
IBA Notice of Full Year 2024 Results and Conference Call
News Preview
FY24 results meeting to take place as a hybrid event on Thursday, 20 March 2025 at 2:30pm CET...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.02.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2024 Financial Results and Announces New Two-Year Data Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH Cirrhosis
News Preview
CONSHOHOCKEN, Pa., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today reports fourth-quarter and year-end 2024 financial results and reviews business highlights....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.02.2025
IMCR
LISTED
NASDAQ
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
News Preview
KIMMTRAK (tebentafusp) Q4 net sales of $84.1 million and $310.0 million for full year 2024; continued growth expected in 2025...
Themefolio
Profiler
Peergroup
© EQS Newswire
26.02.2025
EVT
LISTED
XETR
Evotec announces change in Management Board
News Preview
Laetitia Rouxel steps down as Chief Financial Officer effective 28 February 2025
Paul Hitchin appointed to succeed as Chief Financial Officer effective 1 March 2025
Hamburg, Germany, 26 February 2025:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Financia......
Themefolio
Profiler
Peergroup
© EQS Newswire
26.02.2025
EVT
LISTED
XETR
Evotec gibt Veränderung im Vorstand bekannt
News Preview
Laetitia Rouxel tritt mit Wirkung zum 28. Februar 2025 als Chief Financial Officer zurück
Paul Hitchin mit Wirkung zum 1. März 2025 zum Nachfolger als Chief Financial Officer berufen
Hamburg, 26. Februar 2025:
Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute bekannt, dass ihr......
Themefolio
Profiler
Peergroup
© Globe Newswire
26.02.2025
NSIS B
LISTED
CPH
12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025
News Preview
Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an adjusted EBITDA margin of 37-38%. ...
Themefolio
Profiler
Peergroup
© EQS Newswire
26.02.2025
GXI
LISTED
XETR
Gerresheimer delivers solid results in the financial year 2024 despite market headwinds
News Preview
Gerresheimer delivers solid results in the financial year 2024 despite market headwinds
Organic growth: revenue +2.9%, adjusted EBITDA +4.1%
Destocking in vial business partially offset by strong growth in medical devices
Growth strategy execution: capacity expansions and higher revenue share from solutions for biologics
Bormioli Pharma to boos......
Themefolio
Profiler
Peergroup
© EQS Newswire
26.02.2025
GXI
LISTED
XETR
Gerresheimer liefert im Geschäftsjahr 2024 trotz widriger Marktbedingungen solide Ergebnisse
News Preview
Gerresheimer liefert im Geschäftsjahr 2024 trotz widriger Marktbedingungen solide Ergebnisse
Organisches Wachstum: Umsatz +2,9 %, Adjusted EBITDA +4,1 %
Lagerbestandseffekte bei Injektionsfläschchen teilweise kompensiert durch starkes Wachstum bei Medical Devices
Umsetzung der Wachstumsstrategie: Kapazitätserweiterungen und höherer Umsatzanteil ......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.02.2025
EVT
LISTED
XETR
Evotec Announces Change in Management Board
News Preview
Laetitia Rouxel steps down as Chief Financial Officer effective 28 February 2025Paul Hitchin appointed to succeed as Chief Financial Officer effective 1 March 2025 HAMBURG, GERMANY / ACCESS Newswire / February 26, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced that its Chief Financial O...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.02.2025
GXI
LISTED
XETR
Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds
News Preview
Organic growth: revenue +2.9%, adjusted EBITDA +4.1%Destocking in vial business partially offset by strong growth in medical devicesGrowth strategy execution: capacity expansions and higher revenue share from solutions for biologicsBormioli Pharma to boost revenues and adjusted EBITDA from 2025 with integration well underway DUESSELDORF, GERMANY /...
Themefolio
Profiler
Peergroup
© BusinessWire
25.02.2025
EHAB
LISTED
NYSE
Enhabit Home Health & Hospice to Nominate Stephan Rodgers to Board of Directors
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its board of directors will nominate Stephan Rodgers to stand for election as a director of the company at Enhabit’s 2025 annual meeting of stockholders.
Chairman of the Board Jeff Bolton said, “We look forward to Steve joining us as a director and we believe...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.02.2025
GMAB
LISTED
CPH
Capital Increase in Genmab as a Result of Employee Warrant Exercise
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
